J. Rüssel
11 Papers
5 Citations
J. Rüssel is an academic researcher. The author has contributed to research in topics: Medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome
Michael Bitzer,Jörg G. Albert,Judit Boda-Heggemann,Thomas Brunner,Reiner Caspari,E. de Toni,Frank Dombrowski,Matthias Evert,Andreas Geier,Eleni Gkika,M. Götz,Thomas Helmberger,Ralf Hoffmann,Peter E. Huppert,Achim Kautz,David Krug,Christian la Fougère,Hauke Lang,Philipp Lenz,Tom Lüdde,Andreas H. Mahnken,Silvio Nadalin,Johann Ockenga,Karl J. Oldhafer,Philipp M. Paprottka,P. Pereira,Thorsten Persigehl,Ruben R. Plentz,Jürgen Pohl,Heinrich Recken,Peter Reimer,Jutta Riemer,U. Ritterbusch,Elke Roeb,J. Rüssel,Barbara Schellhaas,Peter Schirmacher,Hans J. Schlitt,Irene Schmid,Andreas Schulze,Daniel Seehofer,Marianne Sinn,Andreas Stengel,Christoph Stoll,Andrea Tannapfel,Annette Taubert,Reina Tholen,Jörg Trojan,I. van Thiel,Arndt Vogel,Thomas Vogl,Frank Wacker,Oliver Waidmann,Heiner Wedemeyer,Henning Wege,Dane Wildner,Marcus-Alexander Wörns,Peter R. Galle,Nisar P. Malek +58 more
TL;DR: Autoren M. Bitzer as mentioned in this paper , S. Voesch1, J. Albert2, P. Bartenstein3, W. Blödt5, T. Brunner6, F. Dombrowski7, M. Follmann9, C. La Fougère10, P Freudenberger11, A. Gkika12, E. Hammes15, R. Hoffmann18, P Huppert20, G. Körber21, D. Lammert24, H. N.
Management des fortgeschrittenen medullären Schilddrüsenkarzinoms
Friedhelm Raue,Martin Fassnacht,Dagmar Führer,Karin Frank-Raue,Markus Luster,Michael C. Kreissl,Stefan P. Müller,Thomas J. Musholt,J. Rüssel,Matthias Schott,C Spitzweg,Vera Tiedje +11 more
TL;DR: The clinical impact of the novel TKI therapy in the setting of long-term follow-up management of patients with advanced metastatic MTC was evaluated and selection criteria for local and systemic treatment based on recent trials and guidelines are discussed.
5
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Michael Bitzer,S. Groß,Jörg G. Albert,Susanne Blödt,Judit Boda-Heggemann,Thomas Brunner,Reiner Caspari,E. de Toni,Frank Dombrowski,Matthias Evert,Markus Follmann,P. Freudenberger,Cihan Gani,Andreas Geier,Eleni Gkika,M. Götz,Thomas Helmberger,Ralf Hoffmann,Peter E. Huppert,David Krug,Christian la Fougère,Hauke Lang,T. Langer,Philipp Lenz,Tom Lüdde,Andreas H. Mahnken,S. Nadalin,Hoa Huu Phuc Nguyen,M. Nothacker,Johann Ockenga,Karl J. Oldhafer,Philipp M. Paprottka,P Pereira,Thorsten Persigehl,Ruben R. Plentz,Jürgen Pohl,Heinrich Recken,Peter Reimer,Jutta Riemer,U. Ritterbusch,Elke Roeb,J. Rüssel,Barbara Schellhaas,Peter Schirmacher,H. J. Schlitt,Irene Schmid,Andreas Schulze,Daniel Seehofer,Marianne Sinn,Andreas Stengel,N. Steubesand,Christoph Stoll,A. Tannapfel,Annette Taubert,Reina Tholen,Jörg Trojan,I. van Thiel,Arndt Vogel,Thomas Vogl,Frank Wacker,Oliver Waidmann,Heiner Wedemeyer,Henning Wege,Dane Wildner,Marcus-Alexander Wörns,Peter R. Galle,Nisar P. Malek +66 more
TL;DR: This guideline (S3-Leitlinie) provides comprehensive diagnostic and therapeutic recommendations for hepatocellular carcinoma (HCC), a type of liver cancer, including risk factors, prevention, and management strategies.
3
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
S. Groß,Michael Bitzer,Jörg G. Albert,Susanne Blödt,Judit Boda-Heggemann,Thomas Brunner,Reiner Caspari,E. de Toni,Frank Dombrowski,Matthias Evert,M. Follmann,P. Freudenberger,Cihan Gani,Andreas Geier,Eleni Gkika,M. Götz,Thomas Helmberger,Ralf Hoffmann,Peter E. Huppert,David Krug,Christian la Fougère,Hauke Lang,T. Langer,Philipp Lenz,Tom Lüdde,Andreas H. Mahnken,S. Nadalin,H. P. Nguyen,M. Nothacker,Johann Ockenga,K. Oldhafer,Philipp M. Paprottka,P Pereira,Thorsten Persigehl,Ruben R. Plentz,Jürgen Pohl,Heinrich Recken,Peter Reimer,Jutta Riemer,U. Ritterbusch,Elke Roeb,J. Rüssel,Barbara Schellhaas,P. Schirmacher,H. J. Schlitt,Irene Schmid,Andreas Schulze,Daniel Seehofer,Marianne Sinn,A. Stengel,N. Steubesand,Christoph Stoll,A. Tannapfel,Annette Taubert,Reina Tholen,Jörg Trojan,I. van Thiel,Arndt Vogel,Thomas Vogl,Frank Wacker,Oliver Waidmann,Heiner Wedemeyer,Henning Wege,Dane Wildner,Marcus-Alexander Wörns,Peter R. Galle,Nisar P. Malek +66 more
TL;DR: This guideline (S3-Leitlinie) provides comprehensive diagnostic and therapeutic recommendations for biliary carcinomas, including cholangiocarcinoma, gallbladder cancer, and bile duct cancer, highlighting risk factors and treatment options.
2
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion
Michael Bitzer,S. Groß,Jörg G. Albert,Susanne Blödt,Judit Boda-Heggemann,Thomas Brunner,Reiner Caspari,E. de Toni,Frank Dombrowski,Matthias Evert,M. Follmann,P. Freudenberger,Cihan Gani,Andreas Geier,Eleni Gkika,M. Götz,Thomas Helmberger,Ralf Hoffmann,Peter E. Huppert,David Krug,Christian la Fougère,Hauke Lang,T. Langer,Philipp Lenz,Tom Lüdde,Andreas H. Mahnken,S. Nadalin,H. P. Nguyen,M. Nothacker,Johann Ockenga,K. Oldhafer,Philipp M. Paprottka,P Pereira,Thorsten Persigehl,Ruben R. Plentz,Jürgen Pohl,Heinrich Recken,Peter Reimer,Jutta Riemer,U. Ritterbusch,Elke Roeb,J. Rüssel,Barbara Schellhaas,P. Schirmacher,H. J. Schlitt,Irene Schmid,Andreas Schulze,Daniel Seehofer,Marianne Sinn,A. Stengel,N. Steubesand,Christoph Stoll,A. Tannapfel,Annette Taubert,Reina Tholen,Jörg Trojan,I. van Thiel,Arndt Vogel,Thomas Vogl,Frank Wacker,Oliver Waidmann,Heiner Wedemeyer,Henning Wege,Dane Wildner,Marcus-Alexander Wörns,Peter R. Galle,Nisar P. Malek +66 more
TL;DR: This guideline provides a concise overview of diagnostic and therapeutic approaches for biliary carcinomas, including cholangiocarcinoma, gallbladder cancer, and bile duct cancer, highlighting risk factors and treatment options.
2